QUESTION # 5 (discussion) If the Committee's answer to Question 4 is No: Please discuss what additional trials should be performed to verify the clinical benefit of Avastin in the treatment of HER2-negative, metastatic breast cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.